Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Shoshana M. Rosenberg"'
Autor:
Megan E. Tesch, Yue Zheng, Shoshana M. Rosenberg, Philip D. Poorvu, Kathryn J. Ruddy, Rulla Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia Borges, Steven E. Come, Craig Snow, Shalender Bhasin, Ann H. Partridge
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Ovarian function suppression (OFS) benefits young women with hormone receptor (HR)-positive breast cancer but they are at risk for ovarian function breakthrough. We assessed endocrine effects of gonadotropin-releasing hormone agonist (GnRHa)
Externí odkaz:
https://doaj.org/article/f3ae8ab8377e4157997d9785ff9388a8
Autor:
Tal Sella, Yue Zheng, Shoshana M. Rosenberg, Kathryn J. Ruddy, Shari I. Gelber, Rulla M. Tamimi, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Lisa A. Carey, Eric P. Winer, Ann H. Partridge
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Extended adjuvant endocrine therapy (eET) improves outcomes in breast cancer survivors. Most studies however have been limited to postmenopausal women, and optimal eET for young survivors is uncertain. We report eET use among participants in
Externí odkaz:
https://doaj.org/article/d8f59f34132643f3837f4026790bf189
Autor:
Adrienne G. Waks, Neelam V. Desai, Tianyu Li, Philip D. Poorvu, Ann H. Partridge, Natalie Sinclair, Laura M. Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jillian Alberti, Julia Deane, Shoshana M. Rosenberg, Elizabeth Frank, Sara M. Tolaney, Ian E. Krop, Nadine M. Tung, Nabihah Tayob, Tari A. King, Elizabeth A. Mittendorf, Eric P. Winer
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract De-escalating adjuvant therapy following pathologic complete response (pCR) to an abbreviated neoadjuvant regimen in human epidermal growth factor receptor 2-positive (HER2+) breast cancer is the focus of international research efforts. Howe
Externí odkaz:
https://doaj.org/article/d0192c11039b44b882550c174a83425c
Autor:
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The excellent outcomes seen in patients treated with adjuvant trastuzumab emtansine (T-DM1) in the ATEMPT trial and the favorable toxicity profile associated with this agent make T-DM1 a potential therapeutic option for select patients with
Externí odkaz:
https://doaj.org/article/e88fcc1488804534afd42026e28dc869
Autor:
Christiana von Hippel, Kate E. Dibble, Shoshana M. Rosenberg, Melissa Bollman-Jenkins, Marisa Weiss, Ann H. Partridge
Publikováno v:
PLoS ONE, Vol 18, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/1ebf376ba8734585a5397e5c8bb524cd
Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer
Autor:
Philip D. Poorvu, Jiani Hu, Yue Zheng, Shari I. Gelber, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Matteo Lambertini, Shoshana M. Rosenberg, Ann H. Partridge
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Young women with breast cancer experience unique treatment and survivorship issues centering on treatment-related amenorrhea (TRA), including fertility preservation and management of ovarian function as endocrine therapy. The Young Women’s
Externí odkaz:
https://doaj.org/article/592ffffed0fa43e097016755a05439e6
Autor:
Erin E. Cook, Shoshana M. Rosenberg, Kathryn J. Ruddy, William T. Barry, Mary Greaney, Jennifer Ligibel, Kim Sprunck-Harrild, Michelle D. Holmes, Rulla M. Tamimi, Karen M. Emmons, Ann H. Partridge
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Young women with breast cancer tend to report lower quality of life and higher levels of stress than older women with breast cancer, and this may have implications for other psychosocial factors including finances. We sought to de
Externí odkaz:
https://doaj.org/article/c000fc52e18d47179b14261fa3dbe95c
Autor:
Luiza Perez, Emily Webster, Leslie Bull, Jesse T. Brewer, Muhammad Danyal Ahsan, Jenny Lin, Sarah R. Levi, Evelyn Cantillo, Eloise Chapman-Davis, Kevin Holcomb, Shoshana M. Rosenberg, Melissa K. Frey
Publikováno v:
Gynecologic Oncology. 173:106-113
Autor:
Christopher J. Gibson, Geoffrey Fell, Tal Sella, Adam S. Sperling, Craig Snow, Shoshana M. Rosenberg, Greg Kirkner, Ashka Patel, Deborah Dillon, Alexander G. Bick, Donna Neuberg, Ann H. Partridge, Peter G. Miller
Publikováno v:
Clinical Cancer Research. :OF1-OF8
Background: Young women treated for breast cancer with cytotoxic therapies are at risk for clonal hematopoiesis of indeterminate potential (CHIP), a condition in which blood cells carrying a somatic mutation associated with hematologic malignancy com
Autor:
Rebecca Lewinsohn, Yue Zheng, Shoshana M. Rosenberg, Kathryn J. Ruddy, Rulla M. Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia F. Borges, Steven Come, Craig Snow, Elizabeth S. Ginsburg, Ann H. Partridge
Publikováno v:
Clinical Breast Cancer. 23:317-323